An announcement from HealthCare Global Enterprises Ltd. ( (IN:HCG) ) is now available.
Healthcare Global Enterprises Limited reported its unaudited financial results for the third quarter and nine months ending December 31, 2024, showing significant growth. The company achieved a 19% year-on-year increase in revenue for Q3FY25, driven by a 20% rise in established centers and a notable 25% increase in emerging centers. This financial performance underscores HCG’s strengthened market position in India’s healthcare sector, potentially benefiting stakeholders through improved profitability and market expansion.
More about HealthCare Global Enterprises Ltd.
HealthCare Global Enterprises Limited (HCG) is one of the leading providers of cancer care in India, operating under the brand name ‘HCG’. The company is focused on delivering specialized oncology services across the country.
YTD Price Performance: 0.80%
Average Trading Volume: 19,705
Current Market Cap: 68.24B INR
For detailed information about HCG stock, go to TipRanks’ Stock Analysis page.